Absorption |
Blood-Brain Barrier | BBB+ | 0.9437 |
Human Intestinal Absorption | HIA+ | 0.9767 |
Caco-2 Permeability | Caco2- | 0.6179 |
P-glycoprotein Substrate | Non-substrate | 0.7405 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9421 |
Non-inhibitor | 0.9666 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9225 |
Distribution |
Subcellular localization | Mitochondria | 0.6070 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6049 |
CYP450 2D6 Substrate | Non-substrate | 0.8078 |
CYP450 3A4 Substrate | Non-substrate | 0.5388 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8681 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9973 |
Non-inhibitor | 0.9057 |
AMES Toxicity | Non AMES toxic | 0.7521 |
Carcinogens | Non-carcinogens | 0.6382 |
Fish Toxicity | High FHMT | 0.5644 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.5901 |
Honey Bee Toxicity | Low HBT | 0.6486 |
Biodegradation | Not ready biodegradable | 0.8732 |
Acute Oral Toxicity | III | 0.5858 |
Carcinogenicity (Three-class) | Non-required | 0.6826 |